Kyrgyzstan vs South Sudan: Number of deaths from cardiovascular diseases
Kyrgyzstan
11,020 deaths
in 2021
South Sudan
10,061 deaths
in 2021
Kyrgyzstan rank
115th
South Sudan rank
117th
Number of deaths from cardiovascular diseases over time
- Kyrgyzstan
- South Sudan
How they compare
Kyrgyzstan currently reports 11,020 deaths against 10,061 deaths in South Sudan, a difference of 959 deaths.
That makes Kyrgyzstan's figure about 1.1 times South Sudan's.
Across all 22 years both countries report, Kyrgyzstan has been ahead every year.
Kyrgyzstan ranks 115th and South Sudan ranks 117th of 194 countries.
Kyrgyzstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15,943 deaths | 4,942 deaths | 11,001 deaths | Kyrgyzstan |
| 2010s | 14,581 deaths | 7,238 deaths | 7,344 deaths | Kyrgyzstan |
| 2020s | 11,725 deaths | 9,963 deaths | 1,762 deaths | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of deaths from cardiovascular diseases, Kyrgyzstan or South Sudan?
- Kyrgyzstan, at 11,020 deaths against 10,061 deaths in South Sudan as of 2021.
- What is the difference in number of deaths from cardiovascular diseases between Kyrgyzstan and South Sudan?
- 959 deaths, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and South Sudan?
- 22 years are reported by both, from 2000 to 2021.
- How do Kyrgyzstan and South Sudan rank globally for number of deaths from cardiovascular diseases?
- Kyrgyzstan ranks 115th and South Sudan ranks 117th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Number of deaths from cardiovascular diseases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from cardiovascular diseases in both sexes.